The validation of QRS morphology with wavelet
Not Applicable
- Conditions
- ife-threatening arrhythmia and serious heart failure
- Registration Number
- JPRN-UMIN000007155
- Lead Sponsor
- Medtronic Japan CO., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients unadapted the wavelet function Patients with advanced atrioventricular block Patients with permanent atrial fibrillation Patients younger than 20 years Patients unwilling to provide written informed consent Patients with any situation that preclude the testing required for all subjects or that otherwise limit study participation required for all subjects (e.g. life expectancy, mental disorder)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the transformation of QRS morphology with both 12 lead ECG and the wavelet in each heart rate
- Secondary Outcome Measures
Name Time Method Evaluate the transformation of QRS morphology with both 12 lead ECG and the wavelet after shock therapy Review incidence of arrhythmia and transformation of QRS morphology in each heart rate.